Literature DB >> 10869818

Neuroprotection of nerve growth factor-loaded microspheres on the D2 dopaminergic receptor positive-striatal neurones in quinolinic acid-lesioned rats: a quantitative autoradiographic assessment with iodobenzamide.

C Gouhier1, S Chalon, M C Venier-Julienne, S Bodard, J Benoit, J Besnard, D Guilloteau.   

Abstract

Huntington's disease (HD) results from the degeneration of striatal neurones, mainly gamma-aminobutyric acid (GABA)ergic projection neurones and lately cholinergic interneurones. The use of trophic factors as agents able to prevent such neural degeneration is a promising strategy. The aim of this study was to validate nerve growth factor-loaded (NGF-loaded) poly-D,L-lactide-co-glycolide (PLGA) microspheres for treatment of HD in a rat model with quinolinic acid lesion using autoradiographic study of D2 dopaminergic receptors (D2R). This target is expressed by about half of striatal neurones and its scintigraphic exploration has already been performed for the follow-up of this degenerative process. Ex vivo autoradiography of D2R performed with iodobenzamide, the widely used ligand for single photo emission computerized tomography, revealed slight neuroprotection. Moreover, tolerance of microspheres was demonstrated by in vitro autoradiography with the marker of gliosis, [(3)H]-PK 11195.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10869818     DOI: 10.1016/s0304-3940(00)01172-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Human multipotent stromal cells (MSCs) increase neurogenesis and decrease atrophy of the striatum in a transgenic mouse model for Huntington's disease.

Authors:  Brooke R Snyder; Andrew M Chiu; Darwin J Prockop; Anthony W S Chan
Journal:  PLoS One       Date:  2010-02-22       Impact factor: 3.240

2.  Quinolinate-induced rat striatal excitotoxicity impairs endoplasmic reticulum Ca2+-ATPase function.

Authors:  Anna M A P Fernandes; Ana M Landeira-Fernandez; Patrícia Souza-Santos; Paulo C Carvalho-Alves; Roger F Castilho
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.